期刊文献+

白介素-10抑制促炎症因子生成保护多巴胺能神经元 被引量:3

Interleukin-10 protects dopaminergic neurons by inhibiting generation of proinflammatory factors
在线阅读 下载PDF
导出
摘要 目的 探讨白介素-10(IL-10)对炎症介导的多巴胺能神经元损伤的影响。方法 于中脑原代神经元-胶质培养体系中,应用脂多糖建立多巴胺能神经元损伤的炎症机制模型,IL-10(10~100ng/mL)与脂多糖(1~100ng/mL)同时处理该培养体系。免疫细胞化学法检测酪氨酸羟化酶阳性神经元的数目,液闪测定法测定多巴胺摄取力,并检测促炎症因子,包括肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)(ELISA法)、一氧化氮(NO)(Griess反应)和超氧化物(细胞色素C还原法)的变化。结果 IL-10(10~100ng/mL)对脂多糖(1~100ng/mL)诱导的中脑多巴胺能神经元损伤具显著的保护作用,且呈剂量依赖性;IL-10也显著降低促炎症因子TNF-α、IL-1β、NO和超氧化物的生成。结论 IL-10抑制促炎症因子生成,保护多巴胺能神经元。 Objective To explore the effect of interleukin-10 (IL-10) on inflammation-induced dopaminergic neurodegeneration. Methods A model of inflammation-induced dopaminergic neurodegeneration was established in mesencephalic neuron-glia cultures by lipopolysaccharides. The culture system was treated by both IL-10(10 -100 ng/mL) and lipopolysaccharides( 1-100 ng/mL). The number and morphology of cells were determined by tyrosine hydroxylase immunostaining. Cell bioactivity was detected by [^3 H ] DA uptake analysis. Besides, the changes of some key proinflammatory factors such as TNF-α, IL-1β (by ELISA), NO (by Griess method) and superoxide (by cytochrome C method) were examined. Results IL-10 (10-100 ng/mL) dose-dependently protected from mesencephalic dopaminergic neurodegeneration induced by lipopolysaccharides (1-100 ng/mL). Besides, IL-10 inhibited the production of TNF-α, IL-1β, NO and superoxide. Conclusion IL-10 may protect mesencephalic dopaminergic neurons by inhibiting the production of proinflammatory factors.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第5期521-524,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30772280) 国家重点基础研究发展计划("973"计划)项目(2006cb500706) 上海市医学领军人才项目(06003)~~
关键词 白介素-10 多巴胺能神经元 炎症 interleukin-10 dopaminergic neurons inflammation
  • 相关文献

参考文献15

  • 1Orr CF, Rowe DR, Halliday GM. An inflammatory review of Parkinson's disease[J]. Prog Neurobiol, 2002, 68(5): 325-340.
  • 2Liu B, Hong JS. Bole of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention [ J ]. J Pharmacol Exp Ther. 2003, 304( 1 ) : 1 - 7.
  • 3Grilli M, Barbieri I, Basudev H, et al. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage[J]. Eur J Neurosci, 2000, 12 ( 7 ) :2265 - 2272.
  • 4Williams K, Dooley N, Ulvestad E, et al. IL-10 production by adult human derived microglial cells [ J]. Neurochem Int, 1996, 29 (1) :55 -64.
  • 5Ledeboer A, Breve JJ, Wierinckx A, et al. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells[ J ]. Eur J Neurosci, 2002, 16 (7) :1175 - 1185.
  • 6Gao HM, Jiang J, Wilson B, et al. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease [ J ]. J Neurochem, 2002, 81 (6) : 1285 - 1297.
  • 7Moore KW, O'Garra A, de Waal Malefyt R, et al. Interleukin-10 [J]. Annu Rev Immunol, 1993, 11:165-190.
  • 8Mizuno T, Sawada M, Marunouchi T, et al. Production of interleukin-10 by mouse glial cells in culture[J]. Biochem Biophys Res Commun, 1994, 205(3) : 1907 - 1915.
  • 9Williams K, Dooley N, Ulvestad E, et al. IL-10 production by adult human derived microglial cells [J] . Neurochem Int, 1996, 29 (1) :55 -64.
  • 10Diab A, Zhu J, Xiao BG, et al. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats[J]. J Neuropathol Exp Neurol, 1997, 56(6):641 - 650.

同被引文献58

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部